BGS - B&G Foods, Inc.
NYSE
->
Consumer Defensive
->
Packaged Foods
Parsippany,
United States
Type: Equity
BGS price evolution
BGS
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $40.32 | $42.46 | $41.09 | |
| Short term investments | ||||
| Net receivables | $167.8 | $142.25 | $136.01 | $143.01 |
| Inventory | $618.09 | $559.59 | $560.59 | $568.98 |
| Total current assets | $882.51 | $796.58 | $785.32 | $802.82 |
| Long term investments | ||||
| Property, plant & equipment | $339.1 | $352.84 | $363.93 | $374.17 |
| Goodwill & intangible assets | $2165.64 | $2171 | $2247.24 | |
| Total noncurrent assets | $2554.97 | $2575.2 | $2660.47 | |
| Total investments | ||||
| Total assets | $3418.41 | $3351.55 | $3360.52 | $3463.29 |
| Current liabilities | ||||
| Accounts payable | $175.74 | $126.21 | $132.91 | $123.78 |
| Deferred revenue | ||||
| Short long term debt | $284.31 | $40.3 | $40.01 | |
| Total current liabilities | $537.63 | $489.97 | $244.24 | $262.42 |
| Long term debt | $1813.96 | $1825.73 | $2064.47 | $2077.54 |
| Total noncurrent liabilities | $2096.57 | $2335.07 | $2365.41 | |
| Total debt | $2110.05 | $2104.77 | $2117.55 | |
| Total liabilities | $2663.11 | $2586.54 | $2579.3 | $2627.83 |
| Shareholders' equity | ||||
| Retained earnings | $756.25 | $748.79 | $744.85 | $785.09 |
| Other shareholder equity | -$10.11 | -$5.86 | $2.68 | $2.6 |
| Total shareholder equity | $765.01 | $781.22 | $835.46 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $41.09 | $45.44 | $33.69 | $52.18 |
| Short term investments | ||||
| Net receivables | $143.01 | $158.04 | $145.28 | $132.94 |
| Inventory | $568.98 | $726.47 | $609.79 | $492.8 |
| Total current assets | $802.82 | $1018.82 | $834.46 | $737.3 |
| Long term investments | ||||
| Property, plant & equipment | $374.17 | $386.29 | $406.64 | $404.07 |
| Goodwill & intangible assets | $2247.24 | $2407.4 | $2571.99 | $2616.07 |
| Total noncurrent assets | $2660.47 | $2822.79 | $2994.09 | $3030.27 |
| Total investments | ||||
| Total assets | $3463.29 | $3841.61 | $3828.55 | $3767.57 |
| Current liabilities | ||||
| Accounts payable | $123.78 | $127.81 | $129.86 | $126.54 |
| Deferred revenue | ||||
| Short long term debt | $40.01 | $65.66 | $12.42 | $11.03 |
| Total current liabilities | $262.42 | $271.53 | $244.29 | $245.65 |
| Long term debt | $2077.54 | $2340.84 | $2323.37 | $2358.05 |
| Total noncurrent liabilities | $2365.41 | $2701.91 | $2664 | $2690.04 |
| Total debt | $2117.55 | $2458.23 | $2335.79 | $2369.08 |
| Total liabilities | $2627.83 | $2973.44 | $2908.29 | $2935.69 |
| Shareholders' equity | ||||
| Retained earnings | $785.09 | $876.8 | $934.19 | $866.83 |
| Other shareholder equity | $2.6 | -$9.35 | -$18.17 | -$35.59 |
| Total shareholder equity | $835.46 | $868.17 | $920.25 | $831.88 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $461.07 | $444.59 | $475.22 | $578.13 |
| Cost of revenue | $352.55 | $366.34 | $452.96 | |
| Gross Profit | $102.34 | $92.04 | $108.88 | $125.17 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $43.13 | $48.61 | $53.25 | |
| Total operating expenses | $51.1 | $48.24 | $124.44 | $83.62 |
| Operating income | $43.8 | -$15.56 | $41.55 | |
| Income from continuing operations | ||||
| EBIT | $44.84 | -$14.52 | $42.51 | |
| Income tax expense | $2.66 | $3.1 | -$12.1 | -$0.29 |
| Interest expense | -$42.17 | $37.81 | $37.83 | $40.23 |
| Net income | ||||
| Net income | $7.46 | $3.94 | -$40.24 | $2.58 |
| Income (for common shares) | $3.94 | -$40.24 | $2.58 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2062.31 | $2163 | $2056.26 | $1967.91 |
| Cost of revenue | $1606.79 | $1753.38 | $1619.3 | $1486.17 |
| Gross Profit | $455.52 | $409.62 | $436.97 | $481.74 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $196.04 | $190.41 | $196.17 | $186.19 |
| Total operating expenses | $375.1 | $311 | $240.89 | $205.3 |
| Operating income | $80.42 | $98.63 | $196.08 | $276.44 |
| Income from continuing operations | ||||
| EBIT | $84.2 | $106.01 | $200.54 | $279 |
| Income tax expense | -$0.94 | -$7.54 | $26.29 | $45.37 |
| Interest expense | $151.33 | $124.92 | $106.89 | $101.63 |
| Net income | ||||
| Net income | -$66.2 | -$11.37 | $67.36 | $131.99 |
| Income (for common shares) | -$66.2 | -$11.37 | $67.36 | $131.99 |
| (in millions $) | 28 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $3.94 | -$40.24 | $2.58 | |
| Operating activities | ||||
| Depreciation | $21.85 | $22.18 | $22.47 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.61 | $1.78 | $1.74 | |
| Total cash flows from operations | $11.29 | $35.12 | $92.08 | |
| Investing activities | ||||
| Capital expenditures | -$6.11 | -$8.06 | $46.89 | |
| Investments | ||||
| Total cash flows from investing | -$19 | -$6.11 | -$8.06 | $46.89 |
| Financing activities | ||||
| Dividends paid | -$45 | -$15.02 | -$14.94 | -$14.94 |
| Sale and purchase of stock | ||||
| Net borrowings | $8 | -$10 | -$443.01 | |
| Total cash flows from financing | -$17.49 | -$7.04 | -$25.53 | -$457.95 |
| Effect of exchange rate | -$0.47 | -$0.27 | -$0.17 | $0.15 |
| Change in cash and equivalents | $13.6 | -$2.14 | $1.37 | -$318.83 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$66.2 | -$11.37 | $67.36 | $131.99 |
| Operating activities | ||||
| Depreciation | $88.38 | $97.44 | $96.86 | $75.66 |
| Business acquisitions & disposals | -$27.29 | $0.5 | -$542.14 | |
| Stock-based compensation | $7.19 | $3.92 | $5.38 | $10.62 |
| Total cash flows from operations | $247.76 | $5.96 | $93.88 | $281.48 |
| Investing activities | ||||
| Capital expenditures | $81.59 | -$11.86 | -$43.34 | -$26.75 |
| Investments | ||||
| Total cash flows from investing | $81.59 | -$39.15 | -$42.84 | -$568.89 |
| Financing activities | ||||
| Dividends paid | -$56.01 | -$133.35 | -$122.9 | -$121.87 |
| Sale and purchase of stock | $73.83 | $65.29 | $125.04 | $2.42 |
| Net borrowings | -$349.63 | $117.5 | -$70.28 | $447.48 |
| Total cash flows from financing | -$333.69 | $45.34 | -$69.84 | $327.95 |
| Effect of exchange rate | -$0.01 | -$0.41 | $0.32 | $0.33 |
| Change in cash and equivalents | -$4.35 | $11.75 | -$18.49 | $40.87 |
News
Fundamentals
| Market cap | $509.02M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 79.16M |
| Revenue | $1.96B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$26.26M |
| Revenue Q/Q | -8.29% |
| Revenue Y/Y | -7.04% |
| P/E ratio | -19.38 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.26 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.33 |
|---|---|
| ROA | -0.77% |
| ROE | N/A |
| Debt/Equity | 3.15 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.64 |
| Quick ratio | 0.49 |